Scarica l'app Stockscreener
324.32
1.76%
5.62
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$318.70
Aprire:
$319.15
Volume 24 ore:
65,079
Relative Volume:
0.16
Capitalizzazione di mercato:
$12.54B
Reddito:
$3.26B
Utile/perdita netta:
$503.61M
Rapporto P/E:
29.50
EPS:
10.9949
Flusso di cassa netto:
$718.54M
1 W Prestazione:
+2.21%
1M Prestazione:
+8.03%
6M Prestazione:
+37.54%
1 anno Prestazione:
+7.04%
Intervallo 1D:
$316.17
$328.10
Intervallo di 1 settimana:
$310.93
$328.10
Portata 52W:
$148.63
$364.42
Evercore Inc Stock (EVR) Company Profile
Nome
Evercore Inc
Settore
Industria
Telefono
212-857-3100
Indirizzo
55 EAST 52ND STREET, NEW YORK, NY
Confronta EVR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EVR
Evercore Inc
|
324.25 | 12.33B | 3.26B | 503.61M | 718.54M | 10.99 |
|
MS
Morgan Stanley
|
171.40 | 268.74B | 113.10B | 16.33B | 10.35B | 9.7425 |
|
GS
Goldman Sachs Group Inc
|
832.40 | 244.50B | 126.58B | 16.67B | 57.26B | 49.23 |
|
SCHW
Charles Schwab Corp
|
93.15 | 163.60B | 27.16B | 8.23B | 20.55B | 4.2633 |
|
HOOD
Robinhood Markets Inc
|
132.28 | 113.25B | 4.23B | 2.19B | -4.36B | 2.4089 |
|
IBKR
Interactive Brokers Group Inc
|
64.73 | 28.32B | 10.17B | 4.13B | 33.07B | 2.0767 |
Evercore Inc Stock (EVR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-09 | Iniziato | Deutsche Bank | Buy |
| 2025-10-03 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-07-14 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-06-23 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-04-08 | Aggiornamento | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-04-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-20 | Aggiornamento | Keefe Bruyette | Mkt Perform → Outperform |
| 2024-09-12 | Iniziato | Wells Fargo | Equal Weight |
| 2024-09-11 | Aggiornamento | Goldman | Neutral → Buy |
| 2024-01-29 | Ripresa | Keefe Bruyette | Mkt Perform |
| 2024-01-09 | Downgrade | UBS | Buy → Neutral |
| 2023-08-22 | Downgrade | Goldman | Buy → Neutral |
| 2023-04-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-12 | Aggiornamento | UBS | Sell → Buy |
| 2023-01-11 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-10-27 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| 2022-09-23 | Downgrade | UBS | Neutral → Sell |
| 2022-01-06 | Downgrade | Goldman | Buy → Neutral |
| 2021-12-08 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-04 | Downgrade | UBS | Buy → Neutral |
| 2021-04-09 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2021-03-19 | Reiterato | Goldman | Buy |
| 2021-01-05 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-12-16 | Iniziato | Seaport Global Securities | Buy |
| 2020-12-01 | Aggiornamento | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-10-02 | Aggiornamento | UBS | Neutral → Buy |
| 2020-08-05 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-07-09 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-03-25 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-01-06 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2019-11-20 | Iniziato | Morgan Stanley | Overweight |
| 2019-08-14 | Aggiornamento | Goldman | Sell → Neutral |
| 2019-06-06 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2019-05-23 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-07 | Downgrade | Goldman | Neutral → Sell |
| 2018-11-06 | Iniziato | Goldman | Neutral |
| 2018-01-09 | Aggiornamento | UBS | Neutral → Buy |
| 2017-05-23 | Downgrade | Goldman | Buy → Neutral |
| 2017-03-27 | Iniziato | Keefe Bruyette | Mkt Perform |
| 2017-02-16 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-02-13 | Downgrade | Instinet | Buy → Neutral |
| 2016-12-14 | Iniziato | BofA/Merrill | Neutral |
| 2016-11-21 | Ripresa | Credit Suisse | Outperform |
Mostra tutto
Evercore Inc Borsa (EVR) Ultime notizie
Evercore ISI Raises Dollar General (NYSE:DG) Price Target to $105.00 - MarketBeat
D-Wave Quantum (QBTS) Stock on December 3, 2025: Evercore’s $44 Call, New U.S. Government Unit and What Comes Next - ts2.tech
D-Wave Quantum initiated with Outperform rating at Evercore ISI (QBTS:NYSE) - Seeking Alpha
Evercore ISI Initiates D-Wave Quantum at Outperform With $44 Price Target - MarketScreener
Charles River Labs Joins Evercore Healthcare Conference - TipRanks
Charles River Laboratories Updates on DSA Trends at Conference - TradingView
D-Wave Quantum stock initiated with Outperform rating by Evercore ISI - Investing.com
NextEra Energy stock rating reiterated at Outperform by Evercore ISI - Investing.com UK
VICI Properties (NYSE:VICI) Downgraded to "In-Line" Rating by Evercore ISI - MarketBeat
CrowdStrike stock price target raised to $460 from $430 at Evercore ISI - Investing.com UK
Marvell stock price target raised to $156 by Evercore ISI on AI growth - Investing.com UK
How risky is Evercore Inc. (QGJ) stock compared to peersQuarterly Growth Report & AI Forecast Swing Trade Picks - Newser
Is Evercore Inc. (QGJ) stock among top earnings playsChart Signals & High Win Rate Trade Alerts - Newser
Key facts: Dollar General Q3 results due Thursday; Evercore raises price target - TradingView
Rexford Industrial Realty (NYSE:REXR) Price Target Lowered to $41.00 at Evercore ISI - MarketBeat
Evercore ISI Group Raises Price Target for CASY to $610 | CASY S - GuruFocus
Dollar General (DG) Price Target Raised by Evercore ISI Group | - GuruFocus
Transcript : Baxter International Inc. Presents at Evercore 8th Annual Healthcare Conference, Dec-02-2025 10 - MarketScreener
Transcript : Mettler-Toledo International Inc. Presents at Evercore 8th Annual Healthcare Conference, Dec-02-2025 09 - MarketScreener
Transcript : Merck & Co., Inc. Presents at Evercore 8th Annual Healthcare Conference, Dec-02-2025 09 - MarketScreener
Evercore CEO to speak at Goldman Sachs financial conference By Investing.com - Investing.com India
Evercore CEO to speak at Goldman Sachs financial conference - Investing.com
Evercore’s Chairman and Chief Executive Officer John S. Weinberg to Participate in the Goldman Sachs 2025 Financial Services Conference on December 9 - MarketScreener
Nkarta to Participate in Evercore Healthcare Conference - GlobeNewswire
Evercore ISI Adjusts Price Target on Dollar General to $105 From $100, Maintains In Line Rating - MarketScreener
Evercore ISI reiterates Meta stock outperform rating, sees WhatsApp as $40B business by 2030 - Investing.com Canada
Will Evercore Inc. (QGJ) stock beat revenue estimatesSwing Trade & Safe Swing Trade Setups - Newser
Why Evercore Inc. Class stock trades below fair valueJuly 2025 Snapshot & Free Real-Time Market Sentiment Alerts - Newser
Did Evercore's (EVR) Nordic Expansion Mark a New Chapter in Its Global Growth Strategy? - Yahoo Finance
Will Evercore Inc. stock recover faster than peersJuly 2025 Chart Watch & High Accuracy Investment Entry Signals - Newser
Evercore ISI Analyst has a Positive Outlook on Moody’s Corporation (MCO) - Yahoo Finance
Can Evercore Inc. (QGJ) stock hold up in economic slowdownVolume Spike & Real-Time Volume Analysis Alerts - Newser
Evercore ISI raises Global Business Travel Group stock price target to $12 - Investing.com Australia
VICI Properties Shares Drop After Downgrade From Evercore ISI - MarketScreener
Evercore hires JPMorgan health-care banking head Ben Carpenter- Bloomberg News - TradingView
Evercore Stock Soars Nearly 38% in 6 Months: Is There More Room to Run? - WV News
Evercore Hires JPMorgan Health-Care Banking Head Ben Carpenter - Bloomberg.com
Evercore ISI Group Lowers Price Target for Rexford Industrial Re - GuruFocus
Caribou Biosciences CEO to address Evercore Healthcare Conference - Traders Union
ProQR Therapeutics N.V. to Participate in 8th Annual Evercore Healthcare Conference on December 4, 2025 - Quiver Quantitative
VICI Properties (VICI) Receives Analyst Downgrade from Evercore ISI Group | VICI Stock News - GuruFocus
ProQR (Nasdaq: PRQR) to join Evercore Healthcare Conference fireside chat Dec. 4 - Stock Titan
Evercore ISI Initiates Coverage on Evommune With Outperform Rating, $40 Price Target - MarketScreener
Evercore ISI initiates Evommune stock with Outperform rating on dermatology potential - Investing.com India
Fractyl Health (Nasdaq: GUTS) to join fireside chat at 8th Annual Evercore Healthcare Conference - Stock Titan
ProMIS Neurosciences to Participate in the 8th Annual Evercore Healthcare Conference - MarketScreener
Syndax Pharmaceuticals (Nasdaq: SNDX) to present fireside chat at 8th Annual Evercore Healthcare Conference - Stock Titan
Evercore ISI Downgrades VICI Properties to In Line From Outperform, Adjusts PT to $32 From $36 - MarketScreener
Evercore ISI Adjusts Price Target on Public Storage to $309 From $315, Maintains In Line Rating - MarketScreener
Top 5 Retail Stocks for 2026 According to Evercore ISI By Investing.com - Investing.com Canada
VICI Properties stock rating downgraded by Evercore ISI on gaming lease concerns - Investing.com India
Evercore Inc Azioni (EVR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.71%
9.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):